Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
3
Neutral
6
Bullish
5
Bearish
8
Neutral
6
Bullish
32
Bearish
5
Neutral
0
Bullish
27
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
KMC Speciality Hospitals (India) Limited is a 450-bed multi-specialty hospital operator in Tiruchirappalli, part of the Kauvery Hospitals Group, providing tertiary-care services including mother & child care, neurosciences, gastro sciences, orthopaedics, critical care and organ transplants supported by 1700+ employees and around 170 doctors.
Operational expansion with the new 200-bed Maa Kauvery block has driven utilisation and revenue: Q3 FY'26 total income rose 33% year-on-year to INR 83.2 Cr, occupancy improved to 82%, IP and OP volumes grew strongly, and blended ARPOB increased 17% versus Q3 FY'25, signalling demand capture from the enlarged capacity.
Profitability has improved markedly: Q3 FY'26 EBITDA rose 50% year-on-year to INR 25.9 Cr (31.1% margin) while PAT jumped 83% to INR 13.7 Cr (16.5% margin), reflecting operating leverage from higher occupancy, better revenue mix driven by mother & child care and disciplined cost controls across employee and other expenses.
Financial position shows strengthening liquidity and lower leverage: Networth grew to INR 195.7 Cr, total cash including deposits is INR 49.0 Cr at Q3 FY'26, debt-to-equity improved to 0.38 and Net Debt/EBITDA fell to 0.28, indicating room to service capex-related debt while maintaining cash buffers for operations and growth.
Healthcare Services
Hospital
1,856 Cr
Low Risk
39.7
59.0
0.3
8.8
124.85
62.50
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY24
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Discovery themes featuring this stockKMC Speciality Hospitals (India) Ltd (KMCSHIL) is currently trading at 113.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
KMC Speciality Hospitals (India) Limited is a 450-bed multi-specialty hospital operator in Tiruchirappalli, part of the Kauvery Hospitals Group, providing tertiary-care services including mother & child care, neurosciences, gastro sciences, orthopaedics, critical care and organ transplants supported by 1700+ employees and around 170 doctors. Operational expansion with the new 200-bed Maa Kauvery block has driven utilisation and revenue: Q3 FY'26 total income rose 33% year-on-year to INR 83.2 Cr, occupancy improved to 82%, IP and OP volumes grew strongly, and blended ARPOB increased 17% versus Q3 FY'25, signalling demand capture from the enlarged capacity. Profitability has improved markedly: Q3 FY'26 EBITDA rose 50% year-on-year to INR 25.9 Cr (31.1% margin) while PAT jumped 83% to INR 13.7 Cr (16.5% margin), reflecting operating leverage from higher occupancy, better revenue mix driven by mother & child care and disciplined cost controls across employee and other expenses. Financial position shows strengthening liquidity and lower leverage: Networth grew to INR 195.7 Cr, total cash including deposits is INR 49.0 Cr at Q3 FY'26, debt-to-equity improved to 0.38 and Net Debt/EBITDA fell to 0.28, indicating room to service capex-related debt while maintaining cash buffers for operations and growth.
Over the past 52 weeks, KMC Speciality Hospitals (India) Ltd has traded between a low of ₹62.50 and a high of ₹124.85. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
KMC Speciality Hospitals (India) Ltd has a market capitalization of approximately 1,856.08. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
KMC Speciality Hospitals (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 39.71 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,856.08 Cr, KMC Speciality Hospitals (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
KMC Speciality Hospitals (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of KMC Speciality Hospitals (India) Ltd is 39.71. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
4980.00 | 2,423 Cr | 34.56 | 7.00 | 0.00 | 20.24 | 15.63 | 9.15 | ||
113.80 | 1,856 Cr | 39.71 | 8.82 | 0.00 | 22.21 | 24.22 | 14.07 | ||
169.75 | 1,828 Cr | 48.86 | 1.82 | 0.00 | 3.72 | 6.20 | 1.89 | ||
150.60 | 1,060 Cr | 25.42 | 5.35 | 2.71 | 26.36 | 23.95 | 0.00 | ||
130.00 | 1,017 Cr | 65.63 | 4.03 | 0.00 | 6.14 | 8.20 | 5.65 | ||
460.70 | 733 Cr | 28.36 | 5.21 | 0.00 | 18.77 | 27.73 | 17.88 | ||
232.05 | 493 Cr | 24.62 | 4.10 | 0.00 | 17.54 | 26.13 | 16.39 | ||
| Median: 7 Co. | — | 169.75 | 1,060 Cr | 34.56 | 5.21 | 0.00 | 18.77 | 23.95 | 9.15 |
Investor Presentation
Filed investor presentation for the quarter and year ended 31 March 2026, outlining company overview, operations, capacity expansion, centres of excellence, leadership and strategy; to be made available on the company website.
Investor Presentation
KMC Speciality Hospitals submitted its Investor Presentation for the quarter and year ended 31 March 2026 to BSE (filed on 5 June 2026) and will make it available on the company website.
